| __timestamp | Viridian Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4320000 | 76392000000 |
| Thursday, January 1, 2015 | 2538000 | 103444000000 |
| Friday, January 1, 2016 | 3337000 | 117351000000 |
| Sunday, January 1, 2017 | 4003000 | 118214000000 |
| Monday, January 1, 2018 | 8386000 | 131537000000 |
| Tuesday, January 1, 2019 | 4461000 | 120074000000 |
| Wednesday, January 1, 2020 | 1050000 | 121982000000 |
| Friday, January 1, 2021 | 2963000 | 132509000000 |
| Saturday, January 1, 2022 | 1772000 | 132703000000 |
| Sunday, January 1, 2023 | 314000 | 139081000000 |
| Monday, January 1, 2024 | 147658000000 |
Unleashing insights
In the ever-evolving landscape of the pharmaceutical and healthcare industry, Walgreens Boots Alliance, Inc. and Viridian Therapeutics, Inc. present a fascinating study in contrasts. Over the past decade, Walgreens Boots Alliance has consistently demonstrated robust revenue growth, peaking at approximately $147 billion in 2024, a 93% increase from 2014. This growth underscores its dominant position in the global market.
Conversely, Viridian Therapeutics, a smaller player, has experienced fluctuating revenues, with a notable peak in 2018. However, by 2023, its revenue had dwindled to just 10% of its 2018 high, highlighting the volatility often faced by emerging biotech firms. The data from 2024 for Viridian is missing, indicating potential challenges or strategic pivots.
This analysis offers a compelling snapshot of how established giants and nimble newcomers navigate the complex healthcare ecosystem.
Comparing Revenue Performance: Genmab A/S or Walgreens Boots Alliance, Inc.?
Walgreens Boots Alliance, Inc. and ACADIA Pharmaceuticals Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Walgreens Boots Alliance, Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Walgreens Boots Alliance, Inc. vs Dynavax Technologies Corporation
Who Generates More Revenue? Walgreens Boots Alliance, Inc. or Travere Therapeutics, Inc.
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: ADMA Biologics, Inc. vs Viridian Therapeutics, Inc.
Vericel Corporation and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: ImmunityBio, Inc. vs Viridian Therapeutics, Inc.
Revenue Insights: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc. Performance Compared